Evidence map›Paper›PMID 21756922›Full record

ReviewMutation research2012

Epidemiologic evidence for a role of telomere dysfunction in cancer etiology.

Jennifer Prescott, Ingrid M Wentzensen, Sharon A Savage, Immaculata De Vivo

Abstract readReview
In one paragraph

Review in Mutation research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 4 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 4 syntheses or guidelines pooled it, 87 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Role of microRNA-494 in tumor progression.American journal of translational research · 2023
    Review
  14. Article
  15. Article
  16. Leukocyte Telomere Length and Its Interaction with Germline Variation in Telomere-Related Genes in Relation to Pancreatic Adenocarcinoma Risk.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Jennifer PrescottDepartment of Medicine, Harvard Medical School, Boston, MA 02115, USA. nhjxp@channing.harvard.edu
Ingrid M Wentzensen
Sharon A Savage
Immaculata De Vivo
Brigham and Women's Hospital · USHarvard University · USNational Cancer Institute · USNational Institutes of Health · US

Funding

COHORT STUDY OF GENETIC SUSCEPTIBILITY TO BREAST CANCERR01CA065725 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI HUNTER, DAVID JOHN · 1996 to 2010
$4.5M
Genome-Wide Association Study of Endometrial CancerR01CA134958 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI DE VIVO, IMMACULATA · 2009 to 2010
$4.3M
Molecular Pathoepidemiology of Endometrial Cancer RiskR01CA082838 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI DE VIVO, IMMACULATA · 1999 to 2015
$4.3M
Intramural NIH HHSNCI NIH HHS CA082838NCI NIH HHS CA134958NCI NIH HHS CA65725NCI NIH HHS R01 CA065725NCI NIH HHS R01 CA082838NCI NIH HHS R01 CA134958
6 · The paper itself

Abstract

Telomeres, the dynamic nucleoprotein structures at the ends of linear chromosomes, maintain the genomic integrity of a cell. Telomere length shortens with age due to the incomplete replication of DNA ends with each cell division as well as damage incurred by oxidative stress. Patterns of telomere shortening, genomic instability, and telomerase expression in many cancer tissues compared to adjacent normal tissue implicate telomere crisis as a common crucial event in malignant transformation. In order to understand the role of telomere length in cancer etiology, most epidemiologic studies have measured average telomere length of peripheral blood or buccal cell DNA as a surrogate tissue biomarker of telomere dysfunction and cancer risk. In this review, we present the results from epidemiologic investigations conducted of telomere length and cancer risk. We note differences in reported associations based on study design, which may be due to biases intrinsic to retrospective studies. Finally, we conclude with study design considerations as future investigations are needed to elucidate the relationship between telomere length and a number of cancer sites.

Indexed as

Epidemiologic MethodsResearch DesignTelomere ShorteningCell Transformation, NeoplasticCellular SenescenceGenomic InstabilityHumansNeoplasmsRisk AssessmentTelomere

Identifiers

PMID21756922
PMCPMC3222719
OpenAlexW1967978928

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.